Page 46 - ISLH 2013 Program

44
35
th IEEE PHOTOVOLTAIC SPECIALISTS CONFERENCE
TORONTO • CANADA
SATURDAY AM POSTER SESSION
P124
Cell Population Data As a Predictor of Stem
Cell Aphaeresis Efficiency
Vera Golubeva
1
,
Elena Sukhacheva
2
,
Julia
Novikova
3
,
Olga Tupizina
3
,
Svetlana Trofimova
3
,
Yekaterina Zueva
1
1
Center for Laboratory Diagnostics, Pavlov State
Medical University, Saint-Petersburg, Russia,
2
Beckman Coulter Eurocenter, Nyon, Switzerland,
3
Hospital N31, Saint-Petersburg, Russia
P126
The Sysmex XN Immature platelet fraction
(
IPF), a monitor of peripheral platelet
destruction or consumption.
David Johnson
University College London Hospital, London,
United Kingdom
P128
Precision Profiles for the CBC Parameters on
the UniCel DxH Series of Hematology Systems
Robert Magari, Liliana Tejidor, La-Wai Lo, Patrick
ONeil
Beckman Coulter, Miami, FL, United States
P130
An investigation into parameters that can
predict Bone marrow Engraftment post
transplantation using the newly introduced
Sysmex XN analyser
Marcelina Michael-Imobioh
University College London Hospitals, London,
United Kingdom
P132
Hematopoietic progenitor cell (HPC) parameter
by the Sysmex XE-2100 counter
Teresa Molero, Melissa Torres, Belen Sevillano,
Angelina Lemes, Julio Gao, Luisa Guerra, Carlos
Rodriguez
Hospital Universitario de Gran Canaria Dr Negrin,
Las Palmas de Gran Canaria, Spain
P134
Evaluation of newred cell parameters on
Beckman Coulter DxH800in the detection of
iron deficiency and thalassaemia carrier
Esda H Y Ng, Junior H W Leung, Y S Lau,
Edmond S K Ma
Hong Kong Sanatorium & Hospital, Happy Valley,
Hong Kong
P136
Evaluation of Pentra MS CRP, a new analyzer
for rapid 5-part differential and CRP with small
amount of whole blood sample
Naoyuki Nomura
1
,
Kensuke Saito
1
,
Tohru Inaba
2
,
Masaki Nakanishi
2
,
Naohisa Fujita
2
1
Horiba Medical, Kyoto, Japan,
2
Kyoto Prefectural
University of Medicine, Kyoto, Japan
P138
The ability of the Sysmex XE 2100/5000
CBC analyzers to detect peripheral blasts in
children with newly diagnosed or relapsed
leukemia
Todd Ogilby
1,2
,
Margaret Roebuck
1,2
,
Elaine
Leung
1,2,3
1
Children’s Hospital of Eastern Ontario, Ottawa,
ON, Canada,
2
Eastern Ontario Regional
Laboratory Association, Ottawa, ON, Canada,
3
University of Ottawa, Ottawa, ON, Canada